Presentation TCT 2013 The EVEREST II Randomized Controlled Trial (RCT): Three Year Outcomes Presenter: Ted Feldman January 31, 2013 REGISTER for free or LOG IN to view this content Mitral Valve Presentation TCT 2013 Up Next Presentation TCT 2013 Effects of Preoperative Tricuspid Regurgitation on Mitral Regurgitation Treatment with the MitraClip Device in High-Risk Patients. Presenter: Maurizio Taramasso January 31, 2013 More slides + Presentation TCT 2013 Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial Presenter: Joe Dizon January 31, 2013 Presentation TCT 2013 Primary Results Following Percutaneous Coronary Intervention with the 38 mm Resolute Zotarolimus-eluting Stent Presenter: Shirish Hiremath January 31, 2013 We Recommend
Presentation TCT 2013 Effects of Preoperative Tricuspid Regurgitation on Mitral Regurgitation Treatment with the MitraClip Device in High-Risk Patients. Presenter: Maurizio Taramasso January 31, 2013
Presentation TCT 2013 Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial Presenter: Joe Dizon January 31, 2013
Presentation TCT 2013 Primary Results Following Percutaneous Coronary Intervention with the 38 mm Resolute Zotarolimus-eluting Stent Presenter: Shirish Hiremath January 31, 2013